Literature DB >> 29978543

The importance of using 24-hour and nighttime blood pressure for the identification of white coat hypertension: Data from the Jackson Heart Study.

D Edmund Anstey1, Lisandro D Colantonio2, Yuichiro Yano3, John N Booth Iii2, Paul Muntner2.   

Abstract

We calculated the prevalence of white coat hypertension (WCH) using out-of-clinic blood pressure (BP) in the daytime period; daytime and 24-hour periods; and daytime, 24-hour, and nighttime periods among 199 African Americans with clinic-measured systolic/diastolic BP ≥140/90 mm Hg in the Jackson Heart Study. Left ventricular mass index (LVMI) was measured among participants with WCH and 374 participants with sustained normotension (ie, non-hypertensive clinic, daytime, 24-hour, and nighttime BP). The prevalence of WCH was 29.6%, 21.1%, and 10.6% using daytime BP; daytime and 24-hour BP; and daytime, 24-hour, and nighttime BP, respectively. Compared with sustained normotension, LVMI was higher when WCH was defined using daytime BP (adjusted mean difference [95% CI] 5.0 [-0.2, 10.1] g/m2 ), but not when defined using daytime and 24-hour BP or daytime, 24-hour, and nighttime BP (adjusted mean difference [95% CI] 3.9 [-1.9, 9.7] and 0.4 [-7.3,8.2] g/m2 , respectively). Using only daytime BP overestimates the prevalence of WCH among African Americans. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  ambulatory blood pressure/home blood pressure monitor; clinical management of high blood pressure (HBP); hypertension in African Americans; hypertension-general; risk assessment

Year:  2018        PMID: 29978543      PMCID: PMC6320734          DOI: 10.1111/jch.13330

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  21 in total

1.  Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement.

Authors:  Albert L Siu
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

2.  Is white-coat hypertension associated with increased cardiovascular and mortality risk?

Authors:  Paul Muntner; John N Booth; Daichi Shimbo; Joseph E Schwartz
Journal:  J Hypertens       Date:  2016-08       Impact factor: 4.844

Review 3.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

4.  Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients.

Authors:  Alejandro de la Sierra; Ernest Vinyoles; José R Banegas; Julián Segura; Manuel Gorostidi; Juan J de la Cruz; Luis M Ruilope
Journal:  J Hypertens       Date:  2017-12       Impact factor: 4.844

5.  The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives.

Authors:  Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Yan Li; Eamon Dolan; Valérie Tikhonoff; Jitka Seidlerová; Tatiana Kuznetsova; Katarzyna Stolarz; Manuel Bianchi; Tom Richart; Edoardo Casiglia; Sofia Malyutina; Jan Filipovsky; Kalina Kawecka-Jaszcz; Yuri Nikitin; Takayoshi Ohkubo; Edgardo Sandoya; Jiguang Wang; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jan A Staessen; Eoin O'Brien
Journal:  Blood Press Monit       Date:  2007-08       Impact factor: 1.444

6.  Is white coat hypertension associated with arterial disease or left ventricular hypertrophy?

Authors:  M C Cavallini; M J Roman; T G Pickering; J E Schwartz; R Pini; R B Devereux
Journal:  Hypertension       Date:  1995-09       Impact factor: 10.190

Review 7.  White-coat hypertension and cardiovascular events: a meta-analysis.

Authors:  Alexandros Briasoulis; Emmanuel Androulakis; Mohan Palla; Nikolaos Papageorgiou; Dimitris Tousoulis
Journal:  J Hypertens       Date:  2016-04       Impact factor: 4.844

Review 8.  Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review.

Authors:  Daichi Shimbo; Marwah Abdalla; Louise Falzon; Raymond R Townsend; Paul Muntner
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

9.  Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population.

Authors:  Kei Asayama; Lutgarde Thijs; Yan Li; Yu-Mei Gu; Azusa Hara; Yan-Ping Liu; Zhenyu Zhang; Fang-Fei Wei; Inés Lujambio; Luis J Mena; José Boggia; Tine W Hansen; Kristina Björklund-Bodegård; Kyoko Nomura; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Katarzyna Stolarz-Skrzypek; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Leonella Luzardo; Kalina Kawecka-Jaszcz; Edgardo Sandoya; Jan Filipovský; Gladys E Maestre; Jiguang Wang; Yutaka Imai; Stanley S Franklin; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2014-08-18       Impact factor: 10.190

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  7 in total

1.  Rationale for Ambulatory and Home Blood Pressure Monitoring Thresholds in the 2017 American College of Cardiology/American Heart Association Guideline.

Authors:  Paul Muntner; Robert M Carey; Kenneth Jamerson; Jackson T Wright; Paul K Whelton
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

2.  Association of thyroid function with white coat hypertension and sustained hypertension.

Authors:  Peng Cai; Yan Peng; YuXi Chen; Li Li; Wei Chu; Yan Wang; Xukai Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-11       Impact factor: 3.738

3.  White coat hypertension: European versus American guidelines-A new dilemma.

Authors:  Cesare Cuspidi; Federico Paoletti; Marijana Tadic
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-08       Impact factor: 3.738

4.  The importance of using 24-hour and nighttime blood pressure for the identification of white coat hypertension: Data from the Jackson Heart Study.

Authors:  D Edmund Anstey; Lisandro D Colantonio; Yuichiro Yano; John N Booth Iii; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-06       Impact factor: 3.738

5.  Long-Term Risk of Progression to Sustained Hypertension in White-Coat Hypertension with Normal Night-Time Blood Pressure Values.

Authors:  João Faria; José Mesquita Bastos; Susana Bertoquini; José Silva; Jorge Polónia
Journal:  Int J Hypertens       Date:  2020-12-22       Impact factor: 2.420

6.  A working definition of white-coat hypertension must include nocturnal blood pressure.

Authors:  Stefano Omboni
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-15       Impact factor: 3.738

7.  Nocturnal hypertension in primary care patients with high office blood pressure: A regional study of the MAPAGE project.

Authors:  Claire Zabawa; Clément Charra; Anne Waldner; Gilles Morel; Marianne Zeller; Adrien Guilloteau; Katia Mazalovic
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-06-08       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.